MDxHealth SA - Income Statement (TTM)

MDxHealth SA
US ˙ NasdaqCM ˙ BE0974461940

Income Statement (TTM)

MDxHealth SA Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 15 18 19 19 21 22 23 25 30 37 46 55 64 70 75 81 85 90 95 99
Change (%) 26.21 0.64 3.95 6.24 8.40 4.71 5.28 23.08 22.79 23.19 21.56 14.77 10.22 7.31 7.19 4.91 6.31 4.95 4.70
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 11 10 11 11 11 12 12 13 15 18 21 23 25 26 28 30 32 35 36 36
Change (%) -2.91 0.83 2.25 3.00 5.56 4.97 9.31 14.91 15.86 15.26 13.53 8.00 4.21 6.80 7.55 7.44 7.70 2.91 0.46
% of Revenue 73.35 56.42 56.53 55.61 53.91 52.50 52.63 54.64 51.01 48.13 45.03 42.06 39.58 37.42 37.24 37.36 38.26 38.77 38.01 36.47
Gross Operating Profit 4 8 8 9 9 11 11 11 15 19 25 32 38 44 47 51 52 55 59 63
Change (%) 106.36 0.40 6.15 10.30 11.72 4.43 0.81 32.92 30.02 30.55 28.14 19.69 14.15 7.62 6.97 3.40 5.44 6.24 7.31
% of Revenue 26.65 43.58 43.47 44.39 46.09 47.50 47.37 45.36 48.99 51.87 54.97 57.94 60.42 62.58 62.76 62.64 61.74 61.23 61.99 63.53
SG&A 31 31 31 30 31 31 34 36 41 49 52 55 56 60 61 63 64 64 64 64
Change (%) -1.60 1.08 -3.06 1.89 2.19 9.84 5.63 11.63 20.65 6.32 5.74 1.24 7.43 1.87 2.41 3.06 -1.01 0.43 -0.50
% of Revenue 213.61 166.53 167.27 156.00 149.61 141.05 147.95 148.43 134.62 132.27 114.15 99.29 87.59 85.37 81.04 77.43 76.06 70.83 67.78 64.41
R&D 4 4 3 5 5 6 7 7 8 5 8 5 9 6 7 8 10 11 11 11
Change (%) 3.14 -24.94 54.85 8.74 3.56 19.40 11.42 8.92 -32.66 43.68 -38.00 78.49 -26.47 13.30 17.01 13.49 10.00 3.17 -3.09
% of Revenue 28.31 23.13 17.25 25.70 26.31 25.13 28.66 30.33 26.84 14.72 17.16 8.75 13.62 9.08 9.59 10.47 11.32 11.72 11.52 10.66
OpEx 46 45 45 46 47 50 53 57 64 76 81 90 91 98 100 105 111 115 117 116
Change (%) -1.61 -1.36 2.06 3.12 6.55 6.26 6.98 12.18 18.19 7.63 10.34 0.93 7.70 2.49 4.85 5.48 3.83 2.13 -0.90
% of Revenue 314.86 245.45 240.57 236.22 229.29 225.37 228.72 232.41 211.81 203.87 178.12 161.68 142.18 138.93 132.69 129.80 130.50 127.45 124.03 117.39
Operating Income -31 -27 -26 -26 -27 -28 -30 -32 -34 -38 -36 -34 -27 -27 -25 -24 -26 -25 -23 -17
Change (%) -14.56 -2.73 0.72 0.84 5.12 7.50 8.30 3.94 14.07 -7.35 -4.02 -21.52 1.73 -9.88 -2.31 7.37 -4.30 -8.15 -24.23
% of Revenue -214.86 -145.45 -140.57 -136.22 -129.29 -125.37 -128.72 -132.41 -111.81 -103.87 -78.12 -61.68 -42.18 -38.93 -32.69 -29.80 -30.50 -27.45 -24.03 -17.39
Interest Expense -1 -1 -1 -1 -1 -2 -2 -2 -3 -3 -3 -5 -11 -6 -4 -6 -5 -8 -10 -10
Change (%) 32.48 -35.93 57.11 0.92 36.71 -0.00 -0.00 75.73 -20.00 25.57 38.28 145.01 -50.22 -19.44 35.13 -14.35 46.57 24.88 2.58
% of Revenue -6.97 -7.31 -4.66 -7.04 -6.69 -8.43 -8.05 -7.65 -10.92 -7.11 -7.25 -8.25 -17.61 -7.95 -5.97 -7.53 -6.14 -8.47 -10.08 -9.88
Net Income -36 -29 -28 -28 -28 -29 -31 -34 -40 -44 -47 -48 -45 -43 -40 -41 -42 -38 -39 -35
Change (%) -19.64 -2.34 0.93 0.51 2.13 7.20 8.74 17.40 10.98 7.81 1.67 -7.16 -3.83 -7.42 2.26 2.80 -9.25 1.83 -10.72
% of Revenue -243.86 -155.27 -150.66 -146.30 -138.41 -130.41 -133.50 -137.89 -131.52 -118.86 -104.02 -87.00 -70.37 -61.40 -52.97 -50.54 -49.52 -42.28 -41.02 -34.98

Source: Capital IQ

Other Listings
DE:O6C1
GB:0O8G
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista